Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will be presenting and hosting 1×1 investor meetings at the 44th Annual J.P. Morgan […]